Table 3.

Summary of pathological data and risk classifications

No.	CD117	CD34	SMA	S100	Vimentin	Actin	Desmin	Mitotic rate/50HPF	Fletcher's risk	Miettinen's risk	UICC TNM	Gold’s point	RFS	DRS	Status of death	Glivec
1	1	0	1	0	N	0	0	0-1	L	L	UICC I	64	103	164	0	0
2	1	1	1	0	1	0	N	0-1	L	L	UICC I	64	RF	146	0	0
3	1	0	1	0	1	0	N	5-8	H	H	UICC IIIB	173	54	61	1	0
4	1	1	1	1	1	0	N	> 10	H	H	UICC IIIB	175	26	35	1	0
5	1	1	1	0	1	N	N	1-2	I	H	UICC II	89	RF	23	1 (lung cancer)	0
6	1	1	0	1	1	1	0	2-3	L	L	UICC I	64	RF	25	1 (pneumonia)	0
7	1	0	1	1	1	N	0	6-8	H	H	UICC IIIB	155	64	73	1	0
8	0	1	0	0	1	1	N	0-1	L	L	UICC I	61	RF	61	1 (stroke)	0
9	1	1	1	1	N	0	N	3-4	L	L	UICC I	55	RF	116	0	0
10	1	0	1	1	N	0	N	0-1	L	L	UICC I	64	101	111	1	0
11	1	1	0	1	N	0	N	5-6	H	H	UICC IIIB	164	29	55	1	0
12	1	1	0	1	1	N	N	> 10	H	H	UICC IIIB	178	15	23	1	0
13	1	1	1	0	1	0	N	0-1	L	L	UICC I	61	RF	102	0	0
14	1	1	1	0	1	1	N	> 10	H	H	UICC IIIB	180	NN	NN	1	0
15	1	1	1	0	N	0	N	1-4	L	L	UICC I	70	62	68	1	0
16	1	1	0	1	1	0	N	5-8	H	H	UICC IIIB	156	37	49	1	0
17	1	1	0	1	N	0	N	> 10	H	H	UICC IIIB	172	21	33	1	0
18	1	1	0	0	N	0	N	2-3	I	H	UICC II	71	53	57	1	0
19	1	0	1	0	N	N	0	0-1	VL	L	UICC I	51	RF	86	0	0
20	1	1	0	0	N	N	0	> 10	H	H	UICC IIIB	190	22	33	1	0
21	1	0	1	0	N	0	N	5-8	H	H	UICC IIIB	184	29	40	1	0
22	1	1	0	0	N	0	0	1-2	I	H	UICC II	71	47	59	1	0
23	1	0	1	1	N	N	0	0-1	VL	L	UICC I	50	RF	75	0	0
24	1	0	1	0	N	N	0	3-5	L	L	UICC I	67	69	73	0	0
25	1	0	1	0	N	0	N	0-1	I	H	UICC II	81	51	71	0	1 (20 mo/PR)
26	1	0	0	1	1	N	N	5-7	H	H	UICC IIIB	155	59	70	0	0
27	1	1	0	0	N	N	0	0-1	I	H	UICC II	71	RF	63	0	1 (24 mo)
28	1	1	1	1	1	N	N	0-1	I	H	UICC II	73	RF	61	0	0

0: Negative; 1: Positive; N: Not evaluated; HPF: High-power fields; VL: Very low; L: Low; I: Intermediate; H: High; RF: Relapse free; NN: Not necessary; PR: Partial remission; UICC: Union for International Cancer Control; TNM: Tumor, nodes, metastasis; RFS: Relapse-free survival; DRS: Disease-related survival; SMA: Smooth muscle actin.